Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Hims & Hers Health Inc (NYSE: HIMS) closed at $61.21 in the last session, down -1.81% from day before closing price of $62.34. In other words, the price has decreased by -$1.81 from its previous closing price. On the day, 35.28 million shares were traded. HIMS stock price reached its highest trading level at $63.67 during the session, while it also had its lowest trading level at $59.7.
Ratios:
We take a closer look at HIMS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 42.46 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 58.23. For the most recent quarter (mrq), Quick Ratio is recorded 1.32 and its Current Ratio is at 1.59. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
On February 18, 2025, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight and also upped its target price recommendation from $42 to $60.
Citigroup Downgraded its Neutral to Sell on January 10, 2025, whereas the target price for the stock was revised from $24 to $25.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 15 ’25 when Okupe Oluyemi sold 11,581 shares for $60.22 per share. The transaction valued at 697,462 led to the insider holds 113,816 shares of the business.
Dudum Andrew sold 128,127 shares of HIMS for $7,482,414 on May 16 ’25. The Chief Executive Officer now owns 89,311 shares after completing the transaction at $58.40 per share. On May 16 ’25, another insider, Dudum Andrew, who serves as the Chief Executive Officer of the company, sold 47,534 shares for $58.25 each. As a result, the insider received 2,768,974 and left with 285,194 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 13700756480 and an Enterprise Value of 13441440768. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 89.10, and their Forward P/E ratio for the next fiscal year is 63.50. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.53. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.68 while its Price-to-Book (P/B) ratio in mrq is 24.92. Its current Enterprise Value per Revenue stands at 7.533 whereas that against EBITDA is 97.63.
Stock Price History:
The Beta on a monthly basis for HIMS is 2.20, which has changed by 2.7854052 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, HIMS has reached a high of $72.98, while it has fallen to a 52-week low of $13.47. The 50-Day Moving Average of the stock is 65.71%, while the 200-Day Moving Average is calculated to be 110.39%.
Shares Statistics:
According to the various share statistics, HIMS traded on average about 37.90M shares per day over the past 3-months and 59218560 shares per day over the past 10 days. A total of 215.21M shares are outstanding, with a floating share count of 190.31M. Insiders hold about 14.98% of the company’s shares, while institutions hold 70.37% stake in the company. Shares short for HIMS as of 1745971200 were 62308786 with a Short Ratio of 1.64, compared to 1743379200 on 57769557. Therefore, it implies a Short% of Shares Outstanding of 62308786 and a Short% of Float of 34.61.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
